Alpha DNA Investment Management LLC Cuts Stake in Entegris, Inc. (NASDAQ:ENTG)

Alpha DNA Investment Management LLC lowered its stake in Entegris, Inc. (NASDAQ:ENTG) by 32.0% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 5,279 shares of the semiconductor company’s stock after selling 2,487 shares during the quarter. Alpha DNA Investment Management LLC’s holdings in Entegris were worth $589,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in ENTG. First Trust Advisors LP lifted its position in Entegris by 270.9% in the first quarter. First Trust Advisors LP now owns 150,164 shares of the semiconductor company’s stock valued at $5,359,000 after purchasing an additional 109,678 shares during the last quarter. Creative Planning raised its holdings in shares of Entegris by 33.1% during the fourth quarter. Creative Planning now owns 4,194 shares of the semiconductor company’s stock valued at $403,000 after acquiring an additional 1,044 shares in the last quarter. NN Investment Partners Holdings N.V. bought a new position in shares of Entegris during the fourth quarter valued at approximately $865,000. California Public Employees Retirement System raised its holdings in shares of Entegris by 5.3% during the fourth quarter. California Public Employees Retirement System now owns 324,708 shares of the semiconductor company’s stock valued at $31,204,000 after acquiring an additional 16,253 shares in the last quarter. Finally, Bailard Inc. bought a new position in shares of Entegris during the fourth quarter valued at approximately $219,000. Hedge funds and other institutional investors own 94.04% of the company’s stock.

NASDAQ ENTG opened at $115.57 on Friday. Entegris, Inc. has a 12 month low of $56.16 and a 12 month high of $126.41. The stock has a market capitalization of $15.66 billion, a PE ratio of 49.60 and a beta of 1.26. The business has a fifty day moving average of $113.58. The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.33 and a current ratio of 4.67.

Entegris (NASDAQ:ENTG) last released its earnings results on Tuesday, April 27th. The semiconductor company reported $0.70 EPS for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.02). Entegris had a return on equity of 27.38% and a net margin of 16.26%. The company had revenue of $512.80 million during the quarter, compared to analysts’ expectations of $518.05 million. During the same period in the prior year, the company posted $0.55 earnings per share. The company’s revenue was up 24.4% on a year-over-year basis. As a group, equities research analysts expect that Entegris, Inc. will post 3.19 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 19th. Investors of record on Wednesday, April 28th were given a dividend of $0.08 per share. The ex-dividend date was Tuesday, April 27th. This represents a $0.32 annualized dividend and a dividend yield of 0.28%. Entegris’s dividend payout ratio (DPR) is presently 12.60%.

In other Entegris news, SVP Joseph Colella sold 1,600 shares of the stock in a transaction dated Monday, April 5th. The stock was sold at an average price of $123.69, for a total value of $197,904.00. Following the transaction, the senior vice president now owns 25,699 shares of the company’s stock, valued at $3,178,709.31. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP James Anthony O’neill sold 6,361 shares of the stock in a transaction dated Wednesday, April 7th. The shares were sold at an average price of $118.67, for a total value of $754,859.87. Following the completion of the transaction, the senior vice president now directly owns 25,498 shares in the company, valued at approximately $3,025,847.66. The disclosure for this sale can be found here. In the last three months, insiders sold 555,562 shares of company stock worth $66,632,939. 1.30% of the stock is owned by corporate insiders.

A number of brokerages recently commented on ENTG. Wolfe Research began coverage on Entegris in a report on Wednesday. They set an “outperform” rating for the company. UBS Group began coverage on Entegris in a report on Wednesday, April 21st. They issued a “neutral” rating and a $120.00 price objective for the company. Deutsche Bank Aktiengesellschaft increased their price objective on Entegris from $120.00 to $125.00 and gave the stock a “hold” rating in a report on Wednesday, April 28th. Finally, Zacks Investment Research upgraded Entegris from a “hold” rating to a “buy” rating and set a $129.00 price objective for the company in a report on Tuesday, April 27th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $108.73.

Entegris Company Profile

Entegris, Inc develops, manufactures, and supplies microcontamination control products, specialty chemicals, and advanced materials handling solutions for manufacturing processes in the semiconductor and other high-technology industries in North America, Taiwan, South Korea, Japan, China, Europe, and Southeast Asia.

Featured Article: What is a Lock-Up Period?

Institutional Ownership by Quarter for Entegris (NASDAQ:ENTG)

Receive News & Ratings for Entegris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entegris and related companies with MarketBeat.com's FREE daily email newsletter.